C-Stem™ outperforms 2D & aggregate cultures in benchmark of cell culture technologies for the mass-production of human induced pluripotent stem cells May 11, 2021
World first: TreeFrog Therapeutics announces the production of a single batch of 15 billion iPS cells in a 10L bioreactor with exponential amplification of 276-fold per week. April 12, 2021
The French Blood Agency announces agreement with TreeFrog Therapeutics to scale-up manufacturing of iPS-derived hematopoietic stem cell transplants November 17, 2020
TreeFrog Therapeutics Awarded the Galien MedStartup Prize for its International Consortium on iPSC Quality with US, Japan & France October 27, 2020
TreeFrog Therapeutics Awarded the Galien MedStartup Prize for its International Consortium on iPSC Quality with US, Japan & France October 27, 2020